Question 1

What will be the duchenne muscular dystrophy (DMD) treatment market size by 2030?

Accepted Answer

The duchenne muscular dystrophy (DMD) treatment market is expected to reach a total market size of US$10,954.230 million by 2030.

Question 2

What is the size of the duchenne muscular dystrophy (DMD) treatment market?

Accepted Answer

Duchenne Muscular Dystrophy (DMD) Treatment Market is valued at US$5,415.322 million in 2025.

Question 3

What are the growth prospects for the duchenne muscular dystrophy (DMD) treatment market?

Accepted Answer

The duchenne muscular dystrophy (DMD) treatment market is expected to grow at a CAGR of 15.13% during the forecast period.

Question 4

Which region holds the largest share of the duchenne muscular dystrophy (DMD) treatment market?

Accepted Answer

The North American region is anticipated to hold a significant share of the duchenne muscular dystrophy (DMD) treatment market.

Question 5

Who are the major players in the duchenne muscular dystrophy (DMD) treatment market?

Accepted Answer

Prominent key market players in the duchenne muscular dystrophy (DMD) treatment market include NIPPON SHINYAKU CO., LTD., ITALFARMACO S.p.A., FibroGen, Inc., DAIICHI SANKYO COMPANY, LIMITED., Solid Biosciences Inc., among others.

Request Free Sample

Duchenne Muscular Dystrophy (DMD) Treatment Market Size, Share, Opportunities, And Trends By Tests (Blood Test, Molecular, Genetic Testing, Electromyography, Muscle Biopsy), By Treatment (Physical Therapy, Orthopedic Devices, Steroids, Others), And By Geography - Forecasts From 2025 To 2030